About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
MF Scheme SnapShots
Check out details of a particular scheme along with the latest NAV for various time periods. You can widen your search on the basis of the Fund House, Category and particular Scheme.
Tata India Pharma & Healthcare Fund(G)-Direct Plan
 
Summary
Fund Name Tata Mutual Fund  
Scheme Name Tata India Pharma & Healthcare Fund(G)-Direct Plan  
AMC Tata Asset Management Private Limited  
Type Open ended scheme  
Category Equity - Sectoral Fund - Pharma & Health Care  
Launch Date 28-Dec-15  
Fund Manager Rajat Srivastava  
Face Value 10  
Custodian Standard Chartered Bank  
Net Assets (Rs. cr) 1239.57  
AMC Details
Tata Asset Management Private Limited
1903, B Wing, Parinee Crescenzo, G Block,
Bandra Kurla Complex, Bandra East,
Mumbai - 400 051
Phone : 022 6282 7777
Fax : +91 (22) 22613782
service@tataamc.com
www.tatamutualfund.com
Registrar & Transfer Agent Details
Computer Age Management Services Limited
178 / 10, Kodambakkam High Road,
Opp. Palmgroove Hotel, M.G.R. Salai, Nungambakkam,
Chennai - 600 034
(044) 39115574, 39115583
(044) 28291521
camslb@camsonline.com
www.camsonline.com
 
 
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.